Long-term experience of captopril in the treatment of primary (essential) hypertension.

1 Forty-one patients with primary (essential) hypertension were treated with captopril alone or in combination with hydrochlorothiazide for 12-36 months. 2 During an initial dose-titration period mean blood pressure fell from 174/111 mm Hg to 134/88 mm Hg supine and from 170/116 mm Hg to 126/93 mm Hg standing after 3 months' treatment. 3 During long-term treatment with unchanged or reduced doses of captopril or hydrochlorothiazide, or both, blood pressure remained substantially reduced. Mean supine blood pressure at 24 months was 136/90 mm Hg and at 36 months 138/90 mm Hg. 4 In 12 patients with clearly defined low renin (essential) hypertension initial blood pressure reduction was less than in patients with normal renin hypertension after 1 month's treatment (162/102 mm Hg v 143/92 mm Hg). After 24 months of treatment, however, the treatment results were similar in the two groups. 5 Except for one case of reversible proteinuria no serious side effects were seen during treatment periods of up to three years. 6 Captopril alone or in combination with hydrochlorothiazide seems to be an effective and safe drug in the long-term treatment of primary hypertension.

[1]  B. Karlberg,et al.  Captopril, an orally active converting enzyme inhibitor, in the treatment of primary hypertension. A controlled long-term study with reference to initial plasma renin activity. , 2009, Acta medica Scandinavica.

[2]  J. Laragh,et al.  Long-term efficacy of captopril in renovascular and essential hypertension. , 1982, The American journal of cardiology.

[3]  T. Lüscher,et al.  Acute and chronic effects of the angiotensin-converting enzyme inhibitor captopril in severe hypertension. , 1982, The American journal of cardiology.

[4]  Captopril: Benefits and Risks in Severe Hypertension , 1980, The Lancet.

[5]  B. Karlberg,et al.  Plasma and urinary aldosterone and their interrelations with blood pressure, plasma renin activity and urinary electrolytes in normotensive subjects. , 1978, Scandinavian journal of clinical and laboratory investigation.

[6]  B. Karlberg,et al.  Relationships between blood pressure, age, plasma renin activity and electrolyte excretion in normotensive subjects. , 1977, Scandinavian journal of clinical and laboratory investigation.

[7]  R. Weale,et al.  THYROID NODULES: THYROID CANCER. , 1964, Lancet.

[8]  R. Tarazi,et al.  Late Resistance to Captopril , 1981 .

[9]  C. van Ypersele de Strihou,et al.  Captopril in the treatment of moderate to severe hypertension. A long-term study. , 1981, Acta Clinica Belgica.

[10]  H. Gavras,et al.  Oral angiotensin-converting enzyme inhibitor in long-term treatment of hypertensive patients. , 1979, Annals of internal medicine.